Subject: Fwd: very nice to meet you
From: nino mamaladze <[email-masked]>
To: [email-masked]
Date: Mon, 23 Mar 2015 11:59:48 +0000

ეკა, გიგზავნი ჯულიეტის რეკომენდაციებს 16-17 ვორკშოფთან დაკავშირებით.

-----Original Message-----
From: "Morgan, Juliette (CDC/CGH/DGHP)" <[email-masked]>
To: "[email-masked]" <[email-masked]>
Date: Mon, 23 Mar 2015 10:03:09 +0000
Subject: very nice to meet you

Dear Nino,
It was very nice to meet with you today.

Please see the communication "highlights" for this workshop that I 
shared
with you already. This are just ideas, just things CDC would like to 
see
mentioned but please feel free to change as you see necessary.

Juliette

*         Purpose of workshop: Bring together national stakeholders 
and
international partners to discuss the timeline and details for Phase 1 
of
Georgia's HCV elimination program.

*         Timeline for HCV elimination: HCV elimination will be a 
process
that will span a number of years.

*         What is the Goal of the HCV elimination program: reduce the
morbidity and mortality caused by Hep C in Georgia, while also
interrupting transmission of this infection and in that way eventually
eliminate it from the Georgian population. This is possible with the
advent of treatments that are highly effective at curing chronically
infected individuals of Hepatitis C (treatment as prevention) but also
other measures of prevention are necessary. The elimination plan
therefore will include not only treatment  for all the estimated 
150,000
Georgians infected with HCV, but also efforts dedicated to the 
prevention
of new infections through education, policy, and regulation. Treatment
availability will occur in phases, and will be dispensed to patients
depending on severity of their disease.

*         How Phase 1 is defined:  Hepatitis C is a disease that
progresses slowly over years, so Georgians who are infected are at all
different stages of disease.  Phase 1 of the elimination plan will 
target
Georgians in later stages of disease who are in the greatest need of
immediate treatment. Once those who are sickest have been treated,
Georgia will move on to phase 2 of the elimination plan a) to treat
people who are in earlier stages of disease and b) to offer screening 
to
those who think they may be at risk for HCV infection but do not yet 
know
their status.

*         Outcomes of March 26 ,27 workshop: Finalize the Phase 1
implementation plan, defining the treatment centers, and providers 
that
will be involved in delivering care and treatment in phase 1; 
clarifying
patient identification algorithms to determine who will be eligible 
for
immediate treatment in phase 1;; develop a registration process for
Georgians who would like to be treated; prepare for the introduction 
of
HCV drugs; review training sessions to ensure that providers have
standard operating procedures for patient registry, treatment, and
monitoring; finalize preparations for a national seroprevalence survey

*         Purpose and timeline of the serosurvey: Beginning in May, 
teams
of public health professionals will randomly select households in 
Georgia
to participate in a national survey to estimate how many people in
Georgia are infected with hepatitis C. Teams will travel to selected
households between May and July of this year. For those who choose to
participate, the teams will take a small blood sample and ask 
questions
related to their health and possible exposure to HCV, and will provide
their test results free of charge. We encourage you to participate in
this important project, since it will help us begin the process of HCV
elimination in Georgia.

Dr. Juliette Morgan
Medical Epidemiologist, CAPT US PHS
CDC Country Director
South Caucasus CDC Office
Phone: +(995 32) 224 46 57
Fax:     +(995 32) 224 46 59
Mobile:  +(995) 599 577 743

NCDC, #9 M Asatiani Str.
Tbilisi, 0186, Georgia
Email: [email-masked]<mailto:[email-masked]>